Berry Genomics Co.Ltd(000710) : Announcement on supplementary correction of the company's 2021 Annual Report

Securities code: Berry Genomics Co.Ltd(000710) securities abbreviation: Berry Genomics Co.Ltd(000710) Announcement No.: 2022030 Berry Genomics Co.Ltd(000710)

Announcement on supplementary corrections to the company's 2021 Annual Report

The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.

Berry Genomics Co.Ltd(000710) (hereinafter referred to as "the company") was posted on cninfo.com on April 15, 2022( http://www.cn.info.com.cn. )Disclosed the company's 2021 annual report. The second Department of management of listed companies of Shenzhen Stock Exchange issued the inquiry letter on Berry Genomics Co.Ltd(000710) 2021 annual report to the company on May 5, 2022 (annual report inquiry letter [2022] No. 165 of the company department, hereinafter referred to as the "annual report inquiry letter"). Now, according to the matters involved in the supplementary disclosure and correction in the annual report inquiry letter, the relevant contents of the company's 2021 annual report are supplementary disclosed and corrected as follows:

1. As of the end of the reporting period, the project budget of Fujian Digital Life Industrial Park, the proportion of accumulated project investment in the budget, the project progress and the accumulated amount of interest capitalization are supplementary disclosed as follows:

Section III Management Discussion and analysis / IV. main business analysis / 1. Overview

……

(8) During the reporting period, the company continued to promote the construction project of Fujian Digital Life Industrial Park Phase I (North District). According to the feasibility study report of the project, the project includes 9 building wet warehouse and laboratory, 10 building gene physical examination center and wet warehouse supporting experimental room, 11 building production plant, 12 building production plant and 13 building Park supporting facilities, with a total construction area of 99768 square meters, including 73610 square meters above the ground and 26157 square meters underground. After the completion of the project, a new gene industry ecosystem covering multiple dimensions of industry, University, research and capital will be formed with phase I (South District). At the same time, relying on the support of local governments and policies, the company will gradually realize the strategic layout of the whole industry chain of the gene industry for the production and manufacturing of upstream reagents and instruments, the research and application of midstream gene detection technology, and downstream gene therapy and big data analysis services.

As of the end of the reporting period, the budget of Fujian Digital Life Industrial Park Phase I (North District), the proportion of cumulative project investment in the budget, the project progress and the cumulative amount of interest capitalization are as follows:

Unit: 10000 yuan

Accumulated interest capital invested in the project

Proportion of project budget input to budget and accumulated fund for project progress

Case amount

The North District of phase I of Fujian Digital Life Industrial Park was established in December 2020

The first phase of the Industrial Park (North 50923182676005 52.55% started in October, and the main structure has no area in 2021) has been capped in October and is currently under construction.

2. The remuneration received by directors, supervisors and senior managers in the company during the reporting period is supplementary disclosed as follows:

Section IV corporate governance / v. directors, supervisors and senior managers / 3. Remuneration of directors, supervisors and senior managers

……

Remuneration of directors, supervisors and senior managers of the company during the reporting period

Unit: 10000 yuan

Obtain pre tax remuneration from the company, whether in the company's relevant name, position, gender and age, and the total remuneration obtained by the associated party

Gao Yang, chairman and general manager, male 42, currently 72.57 no

Hou Ying, director and deputy general manager, female 50, currently 69.14 no

Zhou Daixing director male 56 current 87.41 no

(Zhou Daixing)

Liu Hongfei, chairman of the board of supervisors, male 40, current 60.42 no

Wang Yujing, supervisor, female 39, currently 94.46 no

Chen Hongyan, supervisor, female 36, currently 20.64 no

Song Rui, chairman of the board of supervisors, female 51, leaves office 78.20 no

Secretary of the board of directors, financial secretary

Jin Jinwu director male 43 January 2022119.64 no

(resignation)

Total ----------- 602.48--

3. Correct part of the contents under "section VI important matters / VIII. Appointment and dismissal of accounting firms" in the 2021 annual report (the corrected contents are displayed in bold and underlined): before correction: the accounting firms currently employed

Name of domestic accounting firm: Shanghui accounting firm (special general partnership)

Remuneration of domestic accounting firms (10000 yuan) 290

Continuous years of audit services provided by domestic accounting firms 5

Name of Certified Public Accountants of domestic accounting firm Zhang Wei and Ding Feiyun

Continuous years of audit services provided by domestic accounting firms and certified public accountants 15

……

1. The certified public accountants signing the audit items of the company this year are Mr. Zhang Wei and Ms. Ding Feiyun.

Mr. Zhang Wei began to engage in the audit of Listed Companies in 2007, began to practice in Shanghui accounting firm (special general partnership) in 2007, and began to provide audit services for the company in 2020; Ms. Ding Feiyun began to engage in the audit of Listed Companies in 2010, began to practice in Shanghai accounting firm (special general partnership) in 2010, and began to provide audit services for the company in 2020.

After correction: accounting firm currently employed

Name of domestic accounting firm: Shanghui accounting firm (special general partnership)

Remuneration of domestic accounting firms (10000 yuan) 290

Continuous years of audit services provided by domestic accounting firms 5

Name of Certified Public Accountants of domestic accounting firm Zhang Wei and Ding Feiyun

Continuous years of audit services provided by domestic accounting firms and certified public accountants 1

……

1. The certified public accountants signing the audit items of the company this year are Mr. Zhang Wei and Ms. Ding Feiyun. Mr. Zhang Wei began to engage in the audit of Listed Companies in 2007, began to practice in Shanghui accounting firm (special general partnership) in 2007, and began to provide audit services for the company in 2020; Ms. Ding Feiyun began to engage in the audit of Listed Companies in 2010, began to practice in Shanghai accounting firm (special general partnership) in 2010, and began to provide audit services for the company in 2021.

In addition to the above supplementary corrections, other contents of the company's 2021 annual report remain unchanged. This supplementary correction will not affect the company's 2021 annual performance. The updated 2021 annual report has been disclosed on the same day. The Company Apologizes for the inconvenience caused to investors by the above supplementary correction. Please understand. It is hereby announced.

Berry Genomics Co.Ltd(000710) board of directors may 19, 2022

- Advertisment -